Search research articles
Contact Us
Filters
Showing results (401-410 of 524) with videos related to
Page
of 53
Sort By:
Cancer Research
|
May 11, 2017
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
Sai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, et al.
Cancer Cell
|
March 12, 2015
Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma
Hayley J Sharpe, Gregoire Pau, Gerrit J Dijkgraaf, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Actin Dysregulation Induces Neuroendocrine Plasticity and Immune Evasion: A Vulnerability of Small Cell Lung Cancer
Yoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
The Oncologist
|
August 17, 2023
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer
Arielle Elkrief, Biagio Riccuiti, Joao V Alessi, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
<i>SMARCA4, STK11,</i> and <i>KEAP1</i> co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma
Emily A Costa, Barbara Pereira Mello, Corrin Wohlhieter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2022
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer
Adam J Schoenfeld, Hira A Rizvi, Danish Memon, et al.
Nature Communications
|
December 6, 2025
Actin dysregulation induces neuroendocrine plasticity and immune evasion: a vulnerability of small cell lung cancer
Yoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
Journal for Immunotherapy of Cancer
|
January 20, 2023
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
Natasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2020
<i>MET</i> Exon 14-altered Lung Cancers and MET Inhibitor Resistance
Robin Guo, Michael Offin, A Rose Brannon, et al.
Page
of 53
Search research articles
Search
Showing results (401-410 of 524) with videos related to
Sort By:
Page
of 53
Cancer Research
|
May 11, 2017
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer
Sai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, et al.
Cancer Cell
|
March 12, 2015
Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma
Hayley J Sharpe, Gregoire Pau, Gerrit J Dijkgraaf, et al.
Biorxiv : the Preprint Server for Biology
|
February 24, 2023
Actin Dysregulation Induces Neuroendocrine Plasticity and Immune Evasion: A Vulnerability of Small Cell Lung Cancer
Yoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
The Oncologist
|
August 17, 2023
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer
Arielle Elkrief, Biagio Riccuiti, Joao V Alessi, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
<i>SMARCA4, STK11,</i> and <i>KEAP1</i> co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma
Emily A Costa, Barbara Pereira Mello, Corrin Wohlhieter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2022
Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer
Adam J Schoenfeld, Hira A Rizvi, Danish Memon, et al.
Nature Communications
|
December 6, 2025
Actin dysregulation induces neuroendocrine plasticity and immune evasion: a vulnerability of small cell lung cancer
Yoojeong Seo, Shengzhe Zhang, Jinho Jang, et al.
Journal for Immunotherapy of Cancer
|
January 20, 2023
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
Natasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2020
<i>MET</i> Exon 14-altered Lung Cancers and MET Inhibitor Resistance
Robin Guo, Michael Offin, A Rose Brannon, et al.
Page
of 53